Yamato, Masafumi <br/><br/>
Continuous Hemodiafiltration with an AN69ST Hemofilter (AN69ST-CHDF) as FGF-23-Lowering Therapy.  [electronic resource] 

 -  Clinical laboratory  Dec 2016 
 - 2349-2354 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1433-6510 
<br/><br/><label>Standard No.: </label>10.7754/Clin.Lab.2016.160423  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acrylic Resins--chemistry<br/>Acrylonitrile--analogs & derivatives<br/>Acute Disease--therapy<br/>Adsorption<br/>Aged<br/>Biomarkers--blood<br/>Down-Regulation<br/>Equipment Design<br/>Female<br/>Fibroblast Growth Factor-23<br/>Fibroblast Growth Factors--blood<br/>Hemodiafiltration--instrumentation<br/>Humans<br/>Male<br/>Membranes, Artificial<br/>Middle Aged<br/>Protein Binding<br/>Surface Properties<br/>Time Factors<br/>Treatment Outcome